$10.30
0.151.48%
Pre-Market: 4:01 AM EDT
15 minutes delayed
Iovance Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Iovance Biotherapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.34 | $-0.35 | 2.86 % |
Mar 2024 | 2024-05-09 | $-0.42 | $-0.42 | 0.00 % |
Dec 2023 | 2024-02-28 | $-0.45 | $-0.43 | -4.65 % |
Sep 2023 | 2023-11-07 | $-0.46 | $-0.45 | -2.22 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $31.11M | $27.07M | 14.9 % |
Mar 2024 | 2024-05-09 | $715.00K | $2.07M | -65.5 % |
Sep 2023 | 2023-11-07 | $469.00K | $4.19M | -88.8 % |
Jun 2023 | 2023-08-08 | $238.00K | $3.58M | -93.3 % |
Iovance Biotherapeutics (IOVA) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.34, which beat the estimate of $-0.35.
The Actual Revenue was $31.1M, which beat the estimate of $27.1M.
Browse earnings estimates, EPS, and revenue on all stocks.